An ongoing dialogue on HIV/AIDS, infectious diseases,
February 26th, 2017
Improving Outcomes with ID Consultation: Three More Papers For the Collection
Several years ago, one of my very brilliant colleagues posed an interesting question. Why do ID specialists even exist? “After all,” he said in an accent that happens to be a distinctive mix of several former British colonies. “There is nothing we do that other doctors couldn’t also do, provided they had the motivation.” He had a point — […]
February 19th, 2017
Really Rapid Review — CROI 2017, Seattle
The Conference on Retroviruses and Opportunistic Infections (CROI) returned to Seattle this past week for its 24th meeting. It’s the 4th time CROI has been held in Seattle, an excellent city for a meeting of this size, which includes “only” 4200 people. The convention center is pleasant and user-friendly — big but not cavernous, actually encourages […]
February 13th, 2017
How to Make Preventing Heart Disease in HIV Fun and Exciting: The REPRIEVE Trial
The people researching cardiovascular disease in HIV have quite the challenge. Because when you think about it for a second, we HIV treaters are a pretty spoiled bunch when it comes to therapeutic success. We saw the transformation of a terrifying, incurable, and rapidly progressive disease (AIDS) into something that can be managed for decades — usually […]
February 5th, 2017
Case Report of PrEP Failure: What Can We Learn From It?
The New England Journal of Medicine has published the first well-documented case of HIV pre-exposure prophylaxis (PrEP) failure despite good medication adherence. We heard lots of this information at CROI last year, and again I’m impressed at the extraordinary degree of virologic investigation done on a case from clinical practice. To refresh your memory, here are the critical details […]
Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.